{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:54:28Z","timestamp":1781754868358,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":1467,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1093\/annonc\/mdv375","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T01:55:13Z","timestamp":1442022913000},"page":"2311-2317","source":"Crossref","is-referenced-by-count":28,"title":["Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study"],"prefix":"10.1016","volume":"26","author":[{"given":"C.","family":"Casulo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Hainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.K.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Zelenetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv375_bb0010","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1182\/blood-2010-06-289561","article-title":"InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions","volume":"116","author":"Turner","year":"2010","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0015","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1182\/blood.V118.21.1593.1593","article-title":"The importance of age in prognosis of follicular lymphoma: clinical features and life expectancy of patients younger than 40 years","volume":"118","author":"Lobetti-Bodoni","year":"2011","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.13451","article-title":"Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults","volume":"170","author":"Gangatharan","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdv375_bb0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdv375_bb0035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0040","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0050","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"Dreyling","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0055","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V88.7.2780.bloodjournal8872780","article-title":"High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission","volume":"88","author":"Freedman","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0060","first-page":"102","article-title":"NCCN: non-Hodgkin's lymphoma","volume":"8","author":"Zelenetz","year":"2001","journal-title":"Cancer Control"},{"key":"10.1093\/annonc\/mdv375_bb0065","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in the United States","volume":"23","author":"Swenson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0070","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2013-03-491514","article-title":"Improvements in observed and relative survival in follicular grade 1\u20132 lymphoma during 4 decades: the Stanford University experience","volume":"122","author":"Tan","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","article-title":"Lymphoma in adolescents and young adults","volume":"36","author":"Jaglowski","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0080","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2008.18.1495","article-title":"Follicular lymphoma in the United States: first report of the national LymphoCare study","volume":"27","author":"Friedberg","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/modpathol.2013.50","article-title":"Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients","volume":"26","author":"Duarte","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1093\/annonc\/mdv375_bb0090","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood.V122.21.4273.4273","article-title":"Follicular lymphoma in young adults: clinical characteristics and early treatment outcomes","volume":"122","author":"Gangatharan","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0095","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/10428190410001663680","article-title":"Survival in young patients (less than 40 years) with follicular lymphoma: a population based study by the Scotland and Newcastle Lymphoma Group","volume":"45","author":"Summerfield","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdv375_bb0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V124.21.796.796","article-title":"Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of U.S. Intergroup Trial C10403","volume":"124","author":"Stock","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0105","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1200\/JCO.2008.16.4061","article-title":"Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network","volume":"26","author":"LaCasce","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archpediatrics.2010.4","article-title":"Differences in non-Hodgkin lymphoma survival between young adults and children","volume":"164","author":"Tai","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1093\/annonc\/mdv375_bb0115","series-title":"Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER incidence and survival: 1975\u20132000","author":"Bleyer","year":"2006"},{"key":"10.1093\/annonc\/mdv375_bb0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cppeds.2005.02.001","article-title":"The adolescent and young adult gap in cancer care and outcome","volume":"35","author":"Bleyer","year":"2005","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1093\/annonc\/mdv375_bb0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.seminoncol.2009.07.004","article-title":"Relative lack of conditional survival improvement in young adults with cancer","volume":"36","author":"Bleyer","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0130","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1182\/blood-2010-12-283093","article-title":"Malignant hematologic diseases in adolescents and young adults","volume":"117","author":"Wood","year":"2011","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2012.41.7527","article-title":"Curability of advanced indolent or low-grade follicular lymphomas: time for a new paradigm?","volume":"31","author":"Cabanillas","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdv375_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3324\/haematol.2009.013177","article-title":"Pediatric follicular lymphoma\u2014a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma\u2014Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials","volume":"95","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdv375_bb0150","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1002\/cncr.28350","article-title":"Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study","volume":"119","author":"Martin","year":"2013","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv375_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/11.suppl_3.123","article-title":"Non-Hodgkin's lymphoma: long-term survivors and adverse effects","volume":"11","author":"Epelbaum","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0160","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3324\/haematol.2012.064907","article-title":"A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands","volume":"98","author":"Oerlemans","year":"2013","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdv375_bb0165","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1200\/JCO.2008.17.5026","article-title":"Physical activity and quality of life in adult survivors of non-Hodgkin's lymphoma","volume":"27","author":"Bellizzi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv375_bb0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/bjh.12684","article-title":"Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden","volume":"164","author":"Lorenzo Bermejo","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdv375_bb0175","first-page":"1481","article-title":"Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study","volume":"91","author":"Moser","year":"2006","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdv375_bb0180","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","article-title":"BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma","volume":"125","author":"Correia","year":"2015","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv375_bb0185","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","article-title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","volume":"112","author":"O'Shea","year":"2008","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419363720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419363720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/11\/2311\/16699216\/mdv375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:55:34Z","timestamp":1624521334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419363720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0923753419363720"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv375","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}